Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

AI doctor assistant tested in 1,000 ICU patients to cut errors

NCT ID NCT07293078

First seen Jan 05, 2026 · Last updated Jun 18, 2026 · Updated 28 times

Summary

This study tests whether an AI tool (ChatGPT-5) can help doctors in the intensive care unit (ICU) make better decisions. About 1,000 critically ill adults will be randomly assigned to standard care or AI-assisted care. The AI will analyze patient data and suggest diagnoses and treatments, but doctors can choose to follow or ignore the advice. The main goal is to see if AI reduces medical errors, like missed diagnoses or wrong treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Framingham Union Hospital/MetroWest Medical Center

    Framingham, Massachusetts, 01702, United States

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

acute kidney injury acute respiratory failure Confusion Critical Illness delirium infectious disease with sepsis multiple organ dysfunction syndrome Sepsis Shock

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.